Erratum: Independent prognostic importance of microvessel density in endometrial carcinoma (British Journal of Cancer, (1998), 77, 7, (1140-1144), 10.1038/bjc.1998.189);Independent prognostic importance of microvessel density in endometrial carcinoma

British Journal of Cancer

Volumn 77, Issue 7, 1998, Pages 1140-1144

  Salvesen, H B ^a,b   Iversen, O E ^a   Akslen, L A ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiogenesis; Endometrial carcinoma; Microvessel; Prognosis; Survival

Indexed keywords

NUCLEAR PROTEIN; PROTEIN P53;

ADULT; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL TIME; TUMOR GROWTH;

EID: 0031882361     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1998.347     Document Type: Erratum

References (30)

1. Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA and Lønning PE (1996) Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Med 2: 811-814
2. Abeler VM and Kjørstad KE (1991) Endometrial adenocarcinoma in Norway, a study of a total population. Cancer 67: 3093-3103
3. Abulafia O, Triest WE, Sherer DM, Hansen CC and Ghezzi F (1995) Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol 86: 479-185
4. Baillie CT, Winslet MC and Bradley NJ (1995) Tumour vasculature - a potential therapeutic target. Br J Cancer 72: 257-267
5. Costello P, McCann A, Carney DN and Dervan PA (1995) Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 26: 1181-1184
6. Cox DR (1972) Regression models and life-tables. J R Statist Soc 34: 187-220
7. Dameron KM, Volpert OV, Tainsky MA and Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584
8. Dixon WJ (1992) BMDP Statistical Software Manual. University of California Press: Berkeley
9. Folkman J (1989) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
10. Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, Chine S, Angeletti CA, Harris AL and Bevilacqua G (1995) Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol 177: 57-63
11. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, Barbareschi M, Borrachi P, Marubini E and Pozza F (1994) Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466
12. Geisler JP, Wiemann MC, Zhou Z, Miller GA and Geisler HE (1996) P53 as a prognostic indicator in endometrial cancer. Gynecol Oncol 61: 245-248
13. Hanahan D and Folkman J (1996) Patterns and emerging mechanisms of the angiogenetic switch during tumorigenesis. Cell 86: 353-364
14. Holmgren L, O'Reilly MS and Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1: 149-153
15. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O and Ueshima H (1994) Clinicopathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer 58: 14-19
16. Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, Silverberg SG and Garrett CT (1994) Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 54: 4667-4670
17. Kieser A, Weich HA, Brandner G, Marmè D and Kolch W (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969
18. Kirschner CV, Alanis-Amezcua JM, Martin VG, Luna N, Morgan E, Yang JJ and Yordan EL (1996) Angiogenesis factor in endometrial carcinoma: a new prognostic indicator? Am J Obst Gynecol 174: 1879-1884
19. Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC and Berchuck A (1994) Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial carcinoma. Cancer 73: 2380-2385
20. Mikuta JJ (1993) International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer 71: 1460-1463
21. Paulsen T, Aas T, Børresen AL, Varhaug JE, Lønning PE and Akslen LA (1997) Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. Int J Cancer 74: 138-140
22. Pisani AL, Barbuto DA, Chen D, Ramos L, Lagasse LD and Karlan BY (1995) HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma. Obstet Gynecol 85: 729-734
23. Reinartz JJ, George E, Lindgren BR and Niehans GA (1994) Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival. Hum Pathol 25: 1075-1083
24. Rose PG (1996) Endometrial carcinoma. N Engl J Med 335: 640-649
25. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG and Wilkinson EJ (1994) Histological Typing of Female Genital Tract Tumours. International Histological Classification of Tumours. World Health Organization. 2nd edn. Springer: Berlin
26. Soong R, Knowles S, Williams KE, Hammond IG, Wysocki SJ and Iacopetta BJ (1996) Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. Br J Cancer 74: 562-567
27. Weidner N (1995) Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19
28. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
29. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887
30. Weidner N, Carrol PR, Flax J, Blumenfeld W and Folkman J (1993) Tumor angiogensis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409